Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators

Journal of Experimental Medicine

Volumn 210, Issue 6, 2013, Pages 1217-1234

  Miki, Yoshimi ^a,b   Yamamoto, Kei ^a   Taketomi, Yoshitaka ^a,b   Sato, Hiroyasu ^a,b   Shimo, Kanako ^a,c   Kobayashi, Tetsuyuki ^a   Ishikawa, Yukio ^d   Ishii, Toshiharu ^d   Nakanishi, Hiroki ^e   Ikeda, Kazutaka ^f   Taguchi, Ryo ^g   Kabashima, Kenji ^h   Arita, Makoto ^i,j   Arai, Hiroyuki ⁱ   Lambeau, Gérard ^k   Bollinger, James M ^l,m   Hara, Shuntaro ^b   Gelb, Michael H ^l,m   Murakami, Makoto ^a,j  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KEIO UNIVERSITY   (Japan)

^g CHUBU UNIVERSITY   (Japan)

^h KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^k CNRS   (France)

^l UNIVERSITY OF WASHINGTON   (United States)

^m UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CYTOKINE; FATTY ACID; GLYCOPROTEIN P 15095; HAPTEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP IID; POLYUNSATURATED FATTY ACID; RESOLVIN D1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; CELL ACTIVATION; CONTACT DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNITY; LIPID ANALYSIS; LIPIDOMICS; LYMPHOID TISSUE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; TH1 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DENDRITIC CELLS; DERMATITIS, CONTACT; FATTY ACIDS, UNSATURATED; GROUP II PHOSPHOLIPASES A2; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; LIPIDS; LYMPHOID TISSUE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHATIDYLETHANOLAMINES; SKIN;

EID: 84880649881     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121887     Document Type: Article

References (82)

1. Allenspach, E.J., M.P. Lemos, P.M. Porrett, L.A. Turka, and T.M. Laufer. 2008. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity. 29:795-806. http://dx.doi.org/10.1016/j.immuni.2008.08.013
2. Ariyama, H., N. Kono, S. Matsuda, T. Inoue, and H. Arai. 2010. Decrease in membrane phospholipid unsaturation induces unfolded protein response. J. Biol. Chem. 285:22027-22035. http://dx.doi.org/10.1074/jbc. M110.126870
3. Balestrieri, B., A. Maekawa, W. Xing, M.H. Gelb, H.R. Katz, and J.P. Arm. 2009. Group V secretory phospholipase A2 modulates phagosome maturationand regulates the innate immune response against Candida albicans. J. Immunol. 182:4891-4898. http://dx.doi.org/10.4049/jimmunol.0803776
4. Bligh, E.G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917. http://dx.doi.org/10.1139/o59-099
5. Boilard, E., Y. Lai, K. Larabee, B. Balestrieri, F. Ghomashchi, D. Fujioka, R. Gobezie, J.S. Coblyn, M.E. Weinblatt, E.M. Massarotti, et al. 2010. A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol. Med. 2:172-187. http://dx.doi.org/10.1002/emmm.201000072
6. Bonventre, J.V., Z. Huang, M.R. Taheri, E. O'Leary, E. Li, M.A. Moskowitz, and A. Sapirstein. 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390:622-625. http://dx.doi.org/10.1038/37635
7. Bostrom, M.A., B.B. Boyanovsky, C.T. Jordan, M.P. Wadsworth, D.J. Taatjes, F.C. de Beer, and N.R. Webb. 2007. Group V secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler. Thromb. Vasc. Biol. 27:600-606. http://dx.doi.org/10.1161/01.ATV.0000257133.60884.44
8. Bowton, D.L., A.A. Dmitrienko, E. Israel, B.G. Zeiher, and G.D. Sides. 2005. Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J. Asthma. 42:65-71. http://dx.doi.org/10.1081/JAS-200044748
9. Bradley, J.D., A.A. Dmitrienko, A.J. Kivitz, O.S. Gluck, A.L. Weaver, C. Wiesenhutter, S.L. Myers, and G.D. Sides. 2005. A randomized, double- blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J. Rheumatol. 32:417-423.
10. Byrum, R.S., J.L. Goulet, J.N. Snouwaert, R.J. Griffiths, and B.H. Koller. 1999. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenaseand leukotriene A4 hydrolase-deficient mice. J. Immunol. 163:6810-6819. http://www.jimmunol.org/content/163/12/6810
11. Chen, Y., and E.A. Dennis. 1998. Expression and characterization of human group V phospholipase A2. Biochim. Biophys. Acta. 1394:57-64. http://dx.doi.org/10.1016/S0005-2760(98)00098-8
12. Curfs, D.M., S.A. Ghesquiere, M.N. Vergouwe, I. van der Made, M.J. Gijbels, D.R. Greaves, J.S. Verbeek, M.H. Hofker, and M.P. de Winther. 2008.Macrophage secretory phospholipase A2 group X enhances antiinflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J. Biol. Chem. 283:21640-21648. http://dx.doi.org/10.1074/jbc. M710584200
13. Danno, K., K. Ikai, and S. Imamura. 1993. Anti-inflammatory effects of eicosapentaenoic acid on experimental skin inflammation models. Arch. Dermatol. Res. 285:432-435. http://dx.doi.org/10.1007/BF00372139
14. Degousee, N., F. Ghomashchi, E. Stefanski, A. Singer, B.P. Smart, N. Borregaard, R. Reithmeier, T.F. Lindsay, C. Lichtenberger, W. Reinisch, et al. 2002. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277:5061-5073. http://dx.doi.org/10.1074/jbc. M109083200
15. den Haan, J.M., S.M. Lehar, and M.J. Bevan. 2000. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696. http://dx.doi.org/10.1084/jem.192.12.1685
16. Diep, Q.N., R.M. Touyz, and E.L. Schiffrin. 2000. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-α ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension. 36:851-855. http://dx.doi.org/10.1161/01.HYP.36.5.851
17. Draper, E., C.M. Reynolds, M. Canavan, K.H. Mills, C.E. Loscher, and H.M. Roche. 2011. Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPAR?. J. Nutr. Biochem. 22:784-790. http://dx.doi.org/10.1016/j.jnutbio.2010.06.009
18. Escoffier, J., I. Jemel, A. Tanemoto, Y. Taketomi, C. Payre, C. Coatrieux, H. Sato, K. Yamamoto, S. Masuda, K. Pernet-Gallay, et al. 2010. Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice. J. Clin. Invest. 120:1415-1428. http://dx.doi.org/10.1172/JCI40494
19. Fickenscher, H., S. Hör, H. Küpers, A. Knappe, S. Wittmann, and H. Sticht. 2002. The interleukin-10 family of cytokines. Trends Immunol. 23:89-96. http://dx.doi.org/10.1016/S1471-4906(01)02149-4
20. Fourcade, O., M.F. Simon, C. Viodé, N. Rugani, F. Leballe, A. Ragab, B. Fournié, L. Sarda, and H. Chap. 1995. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:919-927. http://dx.doi.org/10.1016/0092-8674(95)90295-3
21. Fujioka, D., Y. Saito, T. Kobayashi, T. Yano, H. Tezuka, Y. Ishimoto, N. Suzuki, Y. Yokota, T. Nakamura, J.E. Obata, et al. 2008.Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice. Circulation. 117:2977-2985. http://dx.doi.org/10.1161/CIRCULATIONAHA.107.743997
22. Giannattasio, G., D. Fujioka, W. Xing, H.R. Katz, J.A. Boyce, and B. Balestrieri. 2010. Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J. Immunol. 185:4430-4438. http://dx.doi.org/10.4049/jimmunol.1001384
23. Gomez, P.F., M.H. Pillinger, M. Attur, N. Marjanovic, M. Dave, J. Park, C.O. Bingham III, H. Al-Mussawir, and S.B. Abramson. 2005. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts. J. Immunol. 175:6924-6930. http://www.jimmunol.org/content/175/10/6924
24. Groeger, A.L., C. Cipollina, M.P. Cole, S.R. Woodcock, G. Bonacci, T.K. Rudolph, V. Rudolph, B.A. Freeman, and F.J. Schopfer. 2010. Cyclooxygenase-2 generates anti-inflammatory mediators from ω-3 fatty acids. Nat. Chem. Biol. 6:433-441. http://dx.doi.org/10.1038/nchembio.367
25. Heath, W.R., and F.R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10:1237-1244. http://dx.doi.org/10.1038/ni.1822
26. Henderson, W.R. Jr., E.Y. Chi, J.G. Bollinger, Y.T. Tien, X. Ye, L. Castelli, Y.P. Rubtsov, A.G. Singer, G.K. Chiang, T. Nevalainen, et al. 2007. Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 204:865-877. http://dx.doi.org/10.1084/jem.20070029
27. Honda, T., T. Matsuoka, M. Ueta, K. Kabashima, Y. Miyachi, and S. Narumiya. 2009. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J. Allergy Clin. Immunol. 124:809-818: e2. http://dx.doi.org/10.1016/j.jaci.2009.04.029
28. Ishizaki, J., N. Suzuki, K. Higashino, Y. Yokota, T. Ono, K. Kawamoto, N. Fujii, H. Arita, and K. Hanasaki. 1999. Cloning and characterization of novel mouse and human secretory phospholipase A(2)s. J. Biol. Chem. 274:24973-24979. http://dx.doi.org/10.1074/jbc.274.35.24973
29. Itano, A.A., S.J. McSorley, R.L. Reinhardt, B.D. Ehst, E. Ingulli, A.Y. Rudensky, and M.K. Jenkins. 2003. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 19:47-57. http://dx.doi.org/10.1016/S1074-7613(03)00175-4
30. Kabashima, K., D. Sakata, M. Nagamachi, Y. Miyachi, K. Inaba, and S. Narumiya. 2003. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9:744-749. http://dx.doi.org/10.1038/nm872
31. Lambeau, G., and M.H. Gelb. 2008.Biochemistry and physiology of mammalian secreted phospholipases A2. Annu. Rev. Biochem. 77:495-520. http://dx.doi.org/10.1146/annurev.biochem.76.062405.154007
32. Levy, B.D., C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2:612-619. http://dx.doi.org/10.1038/89759
33. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420:868-874. http://dx.doi.org/10.1038/nature01323
34. Lindbom, J., A.G. Ljungman, and C. Tagesson. 2005. Interferon γ-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte- derived macrophages is inhibited by lipopolysaccharide. Inflammation. 29:108-117. http://dx.doi.org/10.1007/s10753-006-9007-x
35. Lu, B., C. Ebensperger, Z. Dembic, Y. Wang, M. Kvatyuk, T. Lu, R.L. Coffman, S. Pestka, and P.B. Rothman. 1998. Targeted disruption of the interferon-g receptor 2 gene results in severe immune defects in mice. Proc. Natl. Acad. Sci. USA. 95:8233-8238. http://dx.doi.org/10.1073/pnas.95.14.8233
36. Lutz, M.B., N. Kukutsch, A.L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods. 223:77-92. http://dx.doi.org/10.1016/S0022-1759(98)00204-X
37. Maldonado-López, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser. 1999. CD8?+ and CD8?- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592. http://dx.doi.org/10.1084/jem.189.3.587
38. McGeachy, M.J. 2011. GM-CSF: the secret weapon in the T(H)17 arsenal. Nat. Immunol. 12:521-522. http://dx.doi.org/10.1038/ni.2044
39. Mitsuishi, M., S. Masuda, I. Kudo, and M. Murakami. 2007. Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species. Biochim. Biophys. Acta. 1771:1389-1396. http://dx.doi.org/10.1016/j.bbalip.2007.09.006
40. Moon, S.H., C.M. Jenkins, D.J. Mancuso, J. Turk, and R.W. Gross. 2008.Smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase A2?. J. Biol. Chem. 283:33975-33987. http://dx.doi.org/10.1074/jbc. M805817200
41. Mukherjee, P.K., V.L. Marcheselli, C.N. Serhan, and N.G. Bazan. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 101:8491-8496. http://dx.doi.org/10.1073/pnas.0402531101
42. Muñoz, N.M., A.Y. Meliton, J.P. Arm, J.V. Bonventre, W. Cho, and A.R. Leff. 2007. Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 179:4800-4807. http://www.jimmunol.org/content/179/7/4800
43. Murakami, M., R.S. Koduri, A. Enomoto, S. Shimbara, M. Seki, K. Yoshihara, A. Singer, E. Valentin, F. Ghomashchi, G. Lambeau, et al. 2001. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276:10083-10096. http://dx.doi.org/10.1074/jbc. M007877200
44. Murakami, M., S. Masuda, K. Ueda-Semmyo, E. Yoda, H. Kuwata, Y. Takanezawa, J. Aoki, H. Arai, H. Sumimoto, Y. Ishikawa, et al. 2005. Group VIB Ca2+-independent phospholipase A2? promotes cellular membrane hydrolysis and prostaglandin production in a manner distinct from other intracellular phospholipases A2. J. Biol. Chem. 280:14028-14041. http://dx.doi.org/10.1074/jbc. M413766200
45. Murakami, M., Y. Taketomi, C. Girard, K. Yamamoto, and G. Lambeau. 2010. Emerging roles of secreted phospholipase A2 enzymes: Lessons from transgenic and knockout mice. Biochimie. 92:561-582. http://dx.doi.org/10.1016/j.biochi.2010.03.015
46. Murakami, M., Y. Taketomi, Y. Miki, H. Sato, T. Hirabayashi, and K. Yamamoto. 2011. Recent progress in phospholipase A2 research: from cells to animals to humans. Prog. Lipid Res. 50:152-192. http://dx.doi.org/10.1016/j.plipres.2010.12.001
47. Nagamachi, M., D. Sakata, K. Kabashima, T. Furuyashiki, T. Murata, E. Segi-Nishida, K. Soontrapa, T. Matsuoka, Y. Miyachi, and S. Narumiya. 2007. Facilitation of Th1-mediated immune response by prostaglandin E receptor EP1. J. Exp. Med. 204:2865-2874. http://dx.doi.org/10.1084/jem.20070773
48. Nakajima, S., T. Honda, D. Sakata, G. Egawa, H. Tanizaki, A. Otsuka, C.S. Moniaga, T. Watanabe, Y. Miyachi, S. Narumiya, and K. Kabashima. 2010. Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J. Immunol. 184:5595-5603. http://dx.doi.org/10.4049/jimmunol.0903260
49. Nakano, H., K.L. Lin, M. Yanagita, C. Charbonneau, D.N. Cook, T. Kakiuchi, and M.D. Gunn. 2009. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 10:394-402. http://dx.doi.org/10.1038/ni.1707
50. Norling, L.V., M. Spite, R. Yang, R.J. Flower, M. Perretti, and C.N. Serhan. 2011. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. J. Immunol. 186:5543-5547. http://dx.doi.org/10.4049/jimmunol.1003865
51. Oh, D.Y., S. Talukdar, E.J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W.J. Lu, S.M. Watkins, and J.M. Olefsky. 2010. GPR120 is an ω-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 142:687-698. http://dx.doi.org/10.1016/j.cell.2010.07.041
52. Ohtsuki, M., Y. Taketomi, S. Arata, S. Masuda, Y. Ishikawa, T. Ishii, Y. Takanezawa, J. Aoki, H. Arai, K. Yamamoto, et al. 2006. Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J. Biol. Chem. 281:36420-36433. http://dx.doi.org/10.1074/jbc. M607975200
53. Pooley, J.L., W.R. Heath, and K. Shortman. 2001. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:5327-5330. http://www.jimmunol.org/content/166/9/5327
54. Pulendran, B., J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C.R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA. 96:1036-1041. http://dx.doi.org/10.1073/pnas.96.3.1036
55. Rajakariar, R., M. Hilliard, T. Lawrence, S. Trivedi, P. Colville-Nash, G. Bellingan, D. Fitzgerald, M.M. Yaqoob, and D.W. Gilroy. 2007. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. USA. 104:20979-20984. http://dx.doi.org/10.1073/pnas.0707394104
56. Ramon, S., F. Gao, C.N. Serhan, and R.P. Phipps. 2012. Specialized proresolving mediators enhance human B cell differentiation to antibodysecreting cells. J. Immunol. 189:1036-1042. http://dx.doi.org/10.4049/jimmunol.1103483
57. Rosenson, R.S., C. Hislop, D. McConnell, M. Elliott, Y. Stasiv, N. Wang, and D.D. Waters; PLASMA Investigators. 2009. Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. Lancet. 373:649-658. http://dx.doi.org/10.1016/S0140-6736(09)60403-7
58. Rossi, A., P. Kapahi, G. Natoli, T. Takahashi, Y. Chen, M. Karin, and M.G. Santoro. 2000. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature. 403:103-108. http://dx.doi.org/10.1038/47520
59. Rouault, M., C. Le Calvez, E. Boilard, F. Surrel, A. Singer, F. Ghomashchi, S. Bezzine, S. Scarzello, J. Bollinger, M.H. Gelb, and G. Lambeau. 2007. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry. 46:1647-1662. http://dx.doi.org/10.1021/bi062119b
60. Samuelsson, B., S.E. Dahlén, J.A. Lindgren, C.A. Rouzer, and C.N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 237:1171-1176. http://dx.doi.org/10.1126/science.2820055
61. Satake, Y., B.L. Diaz, B. Balestrieri, B.K. Lam, Y. Kanaoka, M.J. Grusby, and J.P. Arm. 2004. Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 279:16488-16494. http://dx.doi.org/10.1074/jbc. M313748200
62. Sato, H., Y. Taketomi, Y. Isogai, Y. Miki, K. Yamamoto, S. Masuda, T. Hosono, S. Arata, Y. Ishikawa, T. Ishii, et al. 2010. Group III secreted phospholipase A2 regulates epididymal sperm maturation and fertility in mice. J. Clin. Invest. 120:1400-1414. http://dx.doi.org/10.1172/JCI40493
63. Serbina, N.V., T.P. Salazar-Mather, C.A. Biron, W.A. Kuziel, and E.G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 19:59-70. http://dx.doi.org/10.1016/S1074-7613(03)00171-7
64. Serhan, C.N. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25:101-137. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141647
65. Serhan, C.N., S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac. 2002. Resolvins: a family of bioactive products of ω-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196:1025-1037. http://dx.doi.org/10.1084/jem.20020760
66. Serhan, C.N., N. Chiang, and T.E. Van Dyke. 2008.Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8:349-361. http://dx.doi.org/10.1038/nri2294
67. 2IID), a novel member of phospholipase A2 family, is associated with lymphotoxin deficiency. Genes Immun. 1:191-199. http://dx.doi.org/10.1038/sj.gene.6363659
68. Shevach, E.M. 2009. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity. 30:636-645. http://dx.doi.org/10.1016/j.immuni.2009.04.010
69. Straus, D.S., G. Pascual, M. Li, J.S. Welch, M. Ricote, C.H. Hsiang, L.L. Sengchanthalangsy, G. Ghosh, and C.K. Glass. 2000. 15-deoxyd 12,14-prostaglandin J2 inhibits multiple steps in the NF-κ B signaling pathway. Proc. Natl. Acad. Sci. USA. 97:4844-4849. http://dx.doi.org/10.1073/pnas.97.9.4844
70. Suzuki, N., J. Ishizaki, Y. Yokota, K. Higashino, T. Ono, M. Ikeda, N. Fujii, K. Kawamoto, and K. Hanasaki. 2000. Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s. J. Biol. Chem. 275:5785-5793. http://dx.doi.org/10.1074/jbc.275.8.5785
71. Tamura, T., P. Tailor, K. Yamaoka, H.J. Kong, H. Tsujimura, J.J. O'Shea, H. Singh, and K. Ozato. 2005. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J. Immunol. 174:2573-2581. http://www.jimmunol.org/content/174/5/2573
72. Tomobe, Y.I., K. Morizawa, M. Tsuchida, H. Hibino, Y. Nakano, and Y. Tanaka. 2000. Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids. 35:61-69. http://dx.doi.org/10.1007/s11745-000-0495-0
73. Trivedi, S.G., J. Newson, R. Rajakariar, T.S. Jacques, R. Hannon, Y. Kanaoka, N. Eguchi, P. Colville-Nash, and D.W. Gilroy. 2006. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Proc. Natl. Acad. Sci. USA. 103:5179-5184. http://dx.doi.org/10.1073/pnas.0507175103
74. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, et al. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390:618-622. http://dx.doi.org/10.1038/37622
75. Valentin, E., R.S. Koduri, J.C. Scimeca, G. Carle, M.H. Gelb, M. Lazdunski, and G. Lambeau. 1999. Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. J. Biol. Chem. 274:19152-19160. http://dx.doi.org/10.1074/jbc.274.27.19152
76. Villadangos, J.A., and P. Schnorrer. 2007. Intrinsic and cooperative antigenpresenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7:543-555. http://dx.doi.org/10.1038/nri2103
77. von Allmen, C.E., N. Schmitz, M. Bauer, H.J. Hinton, M.O. Kurrer, R.B. Buser, M. Gwerder, S. Muntwiler, T. Sparwasser, R.R. Beerli, and M.F. Bachmann. 2009. Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 106:11673-11678. http://dx.doi.org/10.1073/pnas.0812569106
78. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978-2986. http://www.jimmunol.org/content/164/6/2978
79. Weinrauch, Y., P. Elsbach, L.M. Madsen, A. Foreman, and J. Weiss. 1996. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Invest. 97:250-257. http://dx.doi.org/10.1172/JCI118399
80. Yamamoto, K., Y. Taketomi, Y. Isogai, Y. Miki, H. Sato, S. Masuda, Y. Nishito, K. Morioka, Y. Ishimoto, N. Suzuki, et al. 2011. Hair follicular expression and function of group X secreted phospholipase A2 in mouse skin. J. Biol. Chem. 286:11616-11631. http://dx.doi.org/10.1074/jbc. M110.206714
81. Yao, C., D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15:633-640. http://dx.doi.org/10.1038/nm.1968
82. Yokoyama, M., H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, et al; Japan EPA lipid intervention study (JELIS) Investigators. 2007. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 369:1090-1098. http://dx.doi.org/10.1016/S0140-6736(07)60527-3